Turn Therapeutics TTRX Growth Metrics (2024-2026)

NASDAQ TTRX
$9.74 -0.05 (-0.46%)
As of: Nov 10, 2026 · 1:02 PM EST
Reported Financials

Turn Therapeutics Quarterly Growth Metrics

Periods 7 quarters
Latest Jun 2026

Turn Therapeutics reported revenue growth of -4,801.19% for the quarter ended Jun 2026. These growth metrics cover 7 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Growth MetricsGrowth Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ) 2.13%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 102.57%-38.40%-17.16%555.88%9.54%49.28%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 578.01%266.63%788.51%
Revenue Growth (1y) -4,801.19%
Return on Equity [ROE] (QoQ)ROE (QoQ) -0.01M0.01M0.01M-0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) 784.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.02M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M435.00
Operating Income (QoQ)Op. Inc (QoQ) 51.12%-17.04%-254.94%-40.03%-14.63%43.19%-30.65%
Operating Income Growth (1y)Op. Inc Growth (1y) -184.34%-566.83%-223.68%-19.14%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 51.51%-1.68%-277.55%-53.51%114.34%-455.47%-502.46%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -185.72%184.53%-195.54%-371.59%
Net Income (QoQ) 51.51%-1.68%-277.55%-53.51%114.34%-455.47%-502.46%
Net Income Growth (1y) -185.72%184.53%-195.54%-371.59%
Net Cash Flow (QoQ)NCF (QoQ) 735.17%135.57%-105.29%2,321.67%217.19%-115.84%
Net Cash Flow Growth (1y)NCF Growth (1y) 2,210.04%777.32%-159.00%
Income After Tax (QoQ) 51.51%-17.55%-259.77%-39.66%-14.20%45.10%-36.07%
Income After Tax Growth (1y) -186.36%-574.46%-215.00%-19.14%
Free Cash Flow (QoQ)FCF (QoQ) 30.77%-67.74%-18.40%-104.40%-34.94%40.77%
Free Cash Flow Growth (1y)FCF Growth (1y) -181.04%-447.82%-93.45%
EPS (Diluted) (QoQ) 51.51%-0.50%-270.15%-50.87%114.48%-434.25%-496.15%
EPS (Diluted) Growth (1y) -172.15%181.26%-170.27%-335.28%
EPS (Basic) (QoQ) 51.51%-0.50%-270.15%-50.87%114.48%-434.25%-496.15%
EPS (Basic) Growth (1y) -172.15%181.26%-170.27%-335.28%
EBT (QoQ) 51.51%-17.55%-259.77%-39.66%-14.20%45.10%-36.07%
EBT Growth (1y) -186.36%-574.46%-215.00%-19.14%
EBIT (QoQ) 51.12%-17.04%-254.94%-40.03%-14.63%43.19%-30.65%
EBIT Growth (1y) -184.34%-566.83%-223.68%-19.14%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 30.77%-67.74%-18.40%-104.40%-34.94%40.77%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -181.04%-447.82%-93.45%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 64.99%61.11%52.58%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -300.93%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 75.12%-83.90%888.16%116.89%-6.55%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 3.09%481.73%222.53%
Assets (QoQ) 183.00%53.30%-9.03%
Assets Growth (1y) 493.60%

Turn Therapeutics Growth Metrics API

Pull Turn Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key. 

https://data.businessquant.com/statements?ticker=TTRX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY
API documentation